Year: 2026
Type: article
Abstract: Background and Objective: Chronic refractory wounds not only persist and delay healing, causing physical and mental suffering to patients and reducing their quality of life but also impose a heavy burden on their families and society. Recombinant human acidic fibroblast growth factor (rh-aFGF), approved in China for decades, is a growth factor with multiple biological effects which can promote the healing of various wounds. It is crucial to develop an rh-aFGF expert consensus for standardizing the clinical application of aFGF and enhancing its clinical value. Methods: The literature related to rh-aFGF, including clinical trials, experimental research, and reviews, was collected and selected from PubMed, Web of Science, Medline, CNKI, and the Wangfang database. The expert recommendations were formed by a combination of clinical research quality, use of the Delphi questionnaire, and consensus reached during meetings involving experts. Results: A total of 12 consensus recommendations for clinical application of rh-aFGF on chronic refractory wounds (CRWs) were successfully formulated, of which seven strong, four moderate, and one weak recommendations were suitable for various clinical sets. The recommendations include specifications for duration of rh-aFGF treatment, dosage, types of wounds, and its combination with other products and dressings. Conclusions: rh-aFGF has vital clinical value for healing chronic wounds. This consensus provides clinicians with a reference to guide the application not only of rh-aFGF but also of other growth factor drugs with similar mechanisms for CRWs.
Source: Pharmaceuticals
DOI: 10.3390/ph19020328
Language: English
Topic: Wound Healing and Treatments
Subfield: Rehabilitation
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,499
Funders: Shandong University, Central South University, Huazhong University of Science and Technology, Jinan University, Nanchang University, Zhejiang University, Shanghai Jiao Tong University, Nantong University, Fourth Military Medical University, Peking University, Southern Medical University, Southern University of Science and Technology, Dalian Medical University, Peking University People's Hospital, Chinese People’s Liberation Army, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Xiangya Hospital, Central South University
OpenAlex ID: W7129587036
FWCI:
Cites:
Cited by:
Related to: